BASF to Enter Medical Foods Market in the US with DIEM Labs

BASF Corporation and Diem Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).

November 3, 2017

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

BASF Corporation and Diem Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like